Karyopharm Therapeutics News

Karyopharm Therapeutics | PRE 14A: Preliminary proxy statements relating to merger or acquisition

Dec 5 16:39 ET

Karyopharm Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Paulson Richard A.

Dec 5 16:19 ET

Karyopharm Therapeutics | 8-K: Current report

Dec 3 07:11 ET

Karyopharm Therapeutics | 3: Initial statement of beneficial ownership of securities-Officer Abate Kristin

Nov 22 16:07 ET

Karyopharm Therapeutics | 8-K: Current report

Nov 20 16:12 ET

Karyopharm Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Avidity Partners Management LP(3.7%),Avidity Partners Management (GP) LLC(3.7%), etc.

Nov 14 16:27 ET

Karyopharm Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(6.13%)

Nov 12 15:54 ET

Karyopharm Therapeutics | 8-K: Current report

Nov 8 16:10 ET

Karyopharm Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Paulson Richard A.

Nov 6 16:08 ET

Karyopharm Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Nov 5 08:06 ET

Karyopharm Therapeutics | 10-Q: Q3 2024 Earnings Report

Nov 5 07:51 ET

Karyopharm Therapeutics | 8-K: Current report

Nov 5 07:46 ET

Karyopharm Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(6.13%)

Nov 4 11:54 ET

Karyopharm Therapeutics | 8-K: Current report

Oct 31 07:46 ET

Karyopharm Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Highbridge Capital Management, LLC(7.2%)

Oct 25 09:37 ET

Karyopharm Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Paulson Richard A.

Oct 7 17:20 ET

Karyopharm Therapeutics | 8-K: Current report

Sep 17 16:15 ET

Karyopharm Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Mano Michael

Sep 5 16:38 ET

Karyopharm Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Paulson Richard A.

Sep 5 16:33 ET

Karyopharm Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Mason Michael

Sep 5 16:33 ET